<b>  Angioedema associated with hyaluronic acid injection </b>
PDF (Spanish)

Keywords

Angioedema associated with hyaluronic acid injection

How to Cite

  Angioedema associated with hyaluronic acid injection . (2025). Revista Alergia México, 72(3), 223. https://doi.org/10.29262/ram.v72i3.1511

Abstract

 

Introduction: Angioedema is a form of localized swelling involving the deeper layers of the skin and mucous membranes, caused by fluid extravasation and lasting for several days. While aging of the skin is a natural process, various compounds such as hyaluronic acid, active amino acids, and peptides are used for their anti-aging properties. However, in some individuals, these substances can overstimulate the immune system, triggering hypersensitivity reactions.

Case report: A 38-year-old woman with a medical history of controlled hypertension and allergy to quinolones. She underwent hyaluronic acid injections in the lips and glabellar region four months before presenting symptoms. Over the last three months, she experienced intermittent, firm, painful, erythematous lip swelling with paresthesia, which did not respond to antihistamines or steroids. Immunological tests showed positive antinuclear antibodies (ANA) with a granular pattern, but rheumatology ruled out autoimmune disease. An ultrasound revealed encapsulation of the injected material.

Conclusion: Hyaluronic acid, widely used in aesthetic medicine, can cause immune mediated adverse effects, including angioedema. Though rare with an incidence of 0.42% such reactions can be serious. Treatment options include dissolving the material using hyaluronidase, applying radiofrequency, administering intralesional corticosteroids, or performing surgery. Type IV hypersensitivity angioedema is rare and may be caused by bacterial proteins or impurities in hyaluronic acid. It does not respond to antihistamines and requires treatment with hyaluronidase, intralesional steroids, radiofrequency, or surgery. This raises questions about the mechanisms underlying the immunogenicity of hyaluronic acid that warrant further investigation.

Keywords: Angioedema; Hypersensitivity; Hyaluronic acid; ANA antibodies.

PDF (Spanish)

References

1. Allijotas-Reig, J., Férnandez-Figueras, M. T., & Puig, L. (2013). Late-onset inflammatory adverse reaction related to soft tissue filler injections. Clinical Reviews in Allergy & Immunology, 45(1), 97–108. https://doi.org/10.1007/s12016-012-8348-5

2. Carruthers, J. D. A., Fagien, S., Rohrich, R. J., Weinkle, S., & Carruthers, A. (2014). Blindness caused by cosmetic filler injection: A review of cause and therapy. Plastic and Reconstructive Surgery, 134(6), 1197–1201. https://doi.org/10.1097/PRS.0000000000000754.00006534-201412000-00016

3. Heydenrych, I., Kapoor, K. M., De Boulle, K., Goodman, G., Swift, A., Kumar, N., & Rahman, E. (2018). A 10-point plan for avoiding hyaluronic acid dermal filler-related complications during facial aesthetic procedures and algorithms for management. Clinical, Cosmetic and Investigational Dermatology, 11, 603–611. https://doi.org/10.2147/CCID.S178127

4. Kroumpouzos, G., & Treacy, P. (2024). Hyaluronidase for dermal filler complications: Review of applications and dosage recommendations. JMIR Dermatology, 7(1), e53468. https://derma.jmir.org/2024/1/e53468/

5. Lowe, N. J., Maxwell, C., Lowe, P., Duick, M. G., & Shah, K. (2001). Hyaluronic acid skin fillers: Adverse reactions and skin testing. Journal of the American Academy of Dermatology, 45(6), 930–933. https://doi.org/10.1067/mjd.2001.117381

6. Machado, R. A., Oliveira, L. Q., Martelli-Júnior, H., Pires, F. R., Carvas, J. B., Rogerio, V. E., Rabelo, V. D., & Coletta, R. D. (2023). Adverse reactions to the injection of face and neck aesthetic filling materials: A systematic review. Medicina Oral, Patología Oral y Cirugía Bucal, 28(3), e278–e284. https://doi.org/10.4317/medoral.25713

7. Obagi, S., Obagi, Z., Altawaty, Y., & Obagi, Z. (2022). Treatment of delayed inflammatory response to hyaluronic acid soft tissue filler in a Pfizer-boosted Moderna-vaccinated individual with hyaluronidase. Surgical & Cosmetic Dermatology, 14, e20220149. https://doi.org/10.5935/scd1984-8773.2022140149

8. Talei, B. (2019). Complications of injectables in the perioral region. Facial Plastic Surgery, 35(2), 182–192. https://doi.org/10.1055/s-0039-1684019

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2025 Revista Alergia México

Downloads

Download data is not yet available.